| Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry SJ Greene, J Butler, NM Albert, AD DeVore, PP Sharma, CI Duffy, CL Hill, ... Journal of the American College of Cardiology 72 (4), 351-366, 2018 | 1165 | 2018 |
| Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial SH Hohnloser, Z Hijazi, L Thomas, JH Alexander, J Amerena, M Hanna, ... European heart journal 33 (22), 2821-2830, 2012 | 748 | 2012 |
| Sex differences in mortality following acute coronary syndromes JS Berger, L Elliott, D Gallup, M Roe, CB Granger, PW Armstrong, ... Jama 302 (8), 874-882, 2009 | 703 | 2009 |
| Addressing extreme propensity scores via the overlap weights F Li, LE Thomas, F Li American journal of epidemiology 188 (1), 250-257, 2019 | 629 | 2019 |
| The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation EC O'Brien, DJN Simon, LE Thomas, EM Hylek, BJ Gersh, JE Ansell, ... European heart journal 36 (46), 3258-3264, 2015 | 538 | 2015 |
| Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II registry BA Steinberg, P Shrader, L Thomas, J Ansell, GC Fonarow, BJ Gersh, ... Journal of the American College of Cardiology 68 (24), 2597-2604, 2016 | 537 | 2016 |
| Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial LE Thomas, F Li, MJ Pencina Jama 323 (23), 2417-2418, 2020 | 500 | 2020 |
| Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial S Halvorsen, D Atar, H Yang, R De Caterina, C Erol, D Garcia, ... European heart journal 35 (28), 1864-1872, 2014 | 497 | 2014 |
| Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in … EM Hylek, C Held, JH Alexander, RD Lopes, R De Caterina, DM Wojdyla, ... Journal of the American College of Cardiology 63 (20), 2141-2147, 2014 | 465 | 2014 |
| Titration of medical therapy for heart failure with reduced ejection fraction SJ Greene, GC Fonarow, AD DeVore, PP Sharma, M Vaduganathan, ... Journal of the American College of Cardiology 73 (19), 2365-2383, 2019 | 456 | 2019 |
| Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation … JV Freeman, DJN Simon, AS Go, J Spertus, GC Fonarow, BJ Gersh, ... Circulation: Cardiovascular Quality and Outcomes 8 (4), 393-402, 2015 | 331 | 2015 |
| Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed … BA Steinberg, ED Peterson, S Kim, L Thomas, BJ Gersh, GC Fonarow, ... Circulation 131 (5), 488-494, 2015 | 316 | 2015 |
| Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: results from ORBIT-AF registry SD Pokorney, DJN Simon, L Thomas, GC Fonarow, PR Kowey, P Chang, ... American heart journal 170 (1), 141-148. e1, 2015 | 307 | 2015 |
| Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis T Yates, SM Haffner, PJ Schulte, L Thomas, KM Huffman, CW Bales, ... The Lancet 383 (9922), 1059-1066, 2014 | 287 | 2014 |
| Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF registry JP Piccini, DJN Simon, BA Steinberg, L Thomas, LA Allen, GC Fonarow, ... JAMA cardiology 1 (3), 282-291, 2016 | 253 | 2016 |
| Digoxin and mortality in patients with atrial fibrillation RD Lopes, R Rordorf, GM De Ferrari, S Leonardi, L Thomas, DM Wojdyla, ... Journal of the American College of Cardiology 71 (10), 1063-1074, 2018 | 245 | 2018 |
| Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial SM Al-Khatib, L Thomas, L Wallentin, RD Lopes, B Gersh, D Garcia, ... European heart journal 34 (31), 2464-2471, 2013 | 244 | 2013 |
| Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation L Wallentin, RD Lopes, M Hanna, L Thomas, A Hellkamp, S Nepal, ... Circulation 127 (22), 2166-2176, 2013 | 228 | 2013 |
| Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) BA Steinberg, S Kim, GC Fonarow, L Thomas, J Ansell, PR Kowey, ... American heart journal 167 (5), 735-742. e2, 2014 | 222 | 2014 |
| Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial JJ Focks, MA Brouwer, DM Wojdyla, L Thomas, RD Lopes, JB Washam, ... Bmj 353, 2016 | 214 | 2016 |
Renato D. LopesProfessor afiliado da EPM/UNIFESPAdresă de e-mail confirmată pe bcri.org.br